San Diego, CA, United States of America

Sayee Gajanan Hegde

This inventor holds 14 USPTO granted patents and 12 published patent applications, plus 3 CIPO patents and 4 EPO patents. Top assignees: Recurium IP Holdings, LLC, Signal Pharmaceuticals, Inc., Pharmacopeia Drug Discovery, Inc.. Active years: 2010-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sayee Gajanan Hegde. Retrieved from https://idiyas.com/inventor/sayee-gajanan-hegde

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 8.6

ph-index = 5

Forward Citations = 147(Granted Patents)


Company Filing History:


Years Active: 2010-2024

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Sayee Gajanan Hegde: Pioneering Inventor from San Diego

Introduction: Sayee Gajanan Hegde is a trailblazing inventor based in San Diego, CA, known for her innovative contributions to various fields.

Latest Patents: Sayee Gajanan Hegde holds several patents in the areas of biotechnology, renewable energy, and medical devices, showcasing her diverse range of expertise.

Career Highlights: With a background in engineering and a passion for problem-solving, Sayee Gajanan Hegde has successfully brought numerous groundbreaking ideas to life through her inventions.

Collaborations: Throughout her career, Sayee Gajanan Hegde has collaborated with leading research institutions, universities, and companies to further develop and commercialize her inventions, making a significant impact in the industry.

Conclusion: Sayee Gajanan Hegde's dedication to innovation and her remarkable contributions to the world of inventions continue to inspire and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…